Ragnhild Hellesnes
Associate professor in oncology
Job description
I work 20% as an associate professor at UiT combined with 50% as consultant and 50% as postodctoral fellow at the Oncology Department, University Hospital of North Norway.
Sophie Dorothea Fosså,
Alv A Dahl,
Lene Thorsen,
Ragnhild Hellesnes,
Cecilie E. Kiserud,
Torgrim Tandstad
et al.:
Mortality and Second Cancer Incidence after Treatment for Testicular Cancer: Psychosocial Health and Lifestyle Are Modifiable Prognostic Factors
Ragnhild Hellesnes,
Tor Åge Myklebust,
Roy M. Bremnes,
Åsa Karlsdottir,
Øivind Kvammen,
Helene Francisca Stigter Negaard
et al.:
Metachronous Contralateral Testicular Cancer in the Cisplatin Era: A Population-Based Cohort Study
Ragnhild Hellesnes,
Tor Åge Myklebust,
Sophie Dorothea Fosså,
Roy M. Bremnes,
Åsa Karlsdottir,
Øivind Kvammen
et al.:
Testicular cancer in the cisplatin era: Causes of death and mortality rates in a population-based cohort
Ragnhild Hellesnes,
Øivind Kvammen,
Tor Åge Myklebust,
Roy M. Bremnes,
Åsa Karlsdottir,
Helene Francisca Stigter Negaard
et al.:
Continuing increased risk of second cancer in long-term testicular cancer survivors after treatment in the cisplatin era
Line Veronika Hjelle,
Per Ole Mobråten Gundersen,
Ragnhild Hellesnes,
Mette Sprauten,
Marianne Brydøy,
Torgrim Tanstad
et al.:
Long-term serum platinum changes and their association with cisplatin-related late effects in testicular cancer survivors
Acta Oncologica 2018 DOI
Torgrim Tandstad,
Ragnhild Hellesnes,
Hege Sagstuen Haugnes,
Åsa Karlsdottir,
Carl W. Langberg,
Helene Francisca Stigter Negaard
et al.:
Late relapses in testicular cancer: Results from a national cohort
Torgrim Tandstad,
Ragnhild Hellesnes,
Åsa Karlsdottir,
Øivind Kvammen,
Carl W. Langberg,
Helene Francisca Stigter Negaard
et al.:
Late relapse in testicular cancer: A report from a national cohort. Oral presentation
2022
The 50 latest publications is shown on this page. See all publications in Cristin here →
Research interests
My main research interests are related to long-term effects after cancer treatment and diagnostics, treatment and follow-up within urologic cancers, mainly testicular cancer.
